Evidence map›Paper›PMID 38786243›Full record

ArticleGels (Basel, Switzerland)2024

Non-Covalent Cross-Linking Hydrogel: A New Method for Visceral Hemostasis.

Chenyu Zhao, Han Wang, Xue Sun, Ying Liu, Jingjing Chen, Jiaqi Li, Fanshan Qiu, Qianqian Han

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenyu ZhaoNational Institutes for Food and Drug Control, Beijing 100050, China.
Han WangNational Institutes for Food and Drug Control, Beijing 100050, China.ORCID 0000-0001-5102-2400
Xue SunNational Institutes for Food and Drug Control, Beijing 100050, China.
Ying LiuBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China.ORCID 0009-0004-2034-385X
Jingjing ChenNational Institutes for Food and Drug Control, Beijing 100050, China.
Jiaqi LiNational Institutes for Food and Drug Control, Beijing 100050, China.
Fanshan QiuNational Institutes for Food and Drug Control, Beijing 100050, China.
Qianqian HanNational Institutes for Food and Drug Control, Beijing 100050, China.

Funding

National Key R&D Program of China No. 2022YFC2401800
6 · The paper itself

Abstract

Excessive blood loss could lead to pathological conditions such as tissue necrosis, organ failure, and death. The limitations of recently developed hemostatic approaches, such as their low mechanical strength, inadequate wet tissue adhesion, and weak hemostatic activity, pose challenges for their application in controlling visceral bleeding. In this study, a novel hydrogel (CT) made of collagen and tannic acid (TA) was proposed. By altering the proportions between the two materials, the mechanical properties, adhesion, and coagulation ability were evaluated. Compared to commercial hydrogels, this hydrogel has shown reduced blood loss and shorter hemostatic time in rat hepatic and cardiac bleeding models. This was explained by the hydrogel's natural hemostatic properties and the significant benefits of wound closure in a moist environment. Better biodegradability was achieved through the non-covalent connection between tannic acid and collagen, allowing for hemostasis without hindering subsequent tissue repair. Therefore, this hydrogel is a new method for visceral hemostasis that offers significant advantages in treating acute wounds and controlling major bleeding. And the production method is simple and efficient, which facilitates its translation to clinical applications.

Indexed as

bioadhesivebiocompatibilitybiodegradabilityhemostasisTannic acid

Identifiers

PMID38786243
PMCPMC11121205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.